carvedilol has been researched along with Tachycardia, Ventricular in 14 studies
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol has been shown to be effective in systemic hypertension and coronary artery disease in patients with end-stage renal disease, on maintenance hemodialysis." | 6.18 | [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients]. ( Cice, G; Di Benedetto, A; Ferrara, L; Iacono, A; Tagliamonte, E, 1998) |
| "Carvedilol treatment improved ventricular function and reduced the incidence of arrhythmic episodes." | 2.69 | Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. ( Cice, G; Ferrara, L; Iacono, A; Tagliamonte, E, 2000) |
| "Carvedilol vs metoprolol was also associated with a 16% reduction in the risk of fast VA." | 1.91 | Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients. ( Aktaş, MK; Chen, AY; Diamond, A; Goldenberg, I; Kutyifa, V; McNitt, S; Polonsky, B; Sampath, R; Steinberg, JS; Younis, A; Zareba, W, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, A | 1 |
| Goldenberg, I | 2 |
| Younis, A | 1 |
| Sampath, R | 1 |
| Kutyifa, V | 1 |
| Chen, AY | 1 |
| McNitt, S | 1 |
| Polonsky, B | 1 |
| Steinberg, JS | 1 |
| Zareba, W | 1 |
| Aktaş, MK | 1 |
| Ruwald, AC | 1 |
| Gislason, GH | 1 |
| Vinther, M | 1 |
| Johansen, JB | 1 |
| Nielsen, JC | 1 |
| Philbert, BT | 1 |
| Torp-Pedersen, C | 1 |
| Riahi, S | 1 |
| Jøns, C | 1 |
| Zhang, J | 2 |
| Zhou, Q | 2 |
| Smith, CD | 2 |
| Chen, H | 1 |
| Tan, Z | 2 |
| Chen, B | 1 |
| Nani, A | 2 |
| Wu, G | 2 |
| Song, LS | 2 |
| Fill, M | 2 |
| Back, TG | 2 |
| Chen, SR | 2 |
| Xiao, Z | 1 |
| Wei, J | 1 |
| Mitchell, LB | 1 |
| Lobo-Vielma, L | 1 |
| Colmenarez-Mendoza, H | 1 |
| Donis, JH | 1 |
| Sanchez, F | 1 |
| Perez, A | 1 |
| Villarroel, V | 1 |
| Dávila, DF | 1 |
| Shimada, YJ | 1 |
| Sato, K | 1 |
| Hanon, S | 1 |
| Schweitzer, P | 1 |
| Vitulano, N | 1 |
| Giubilato, G | 1 |
| Santangeli, P | 1 |
| Ierardi, C | 1 |
| Pieroni, M | 1 |
| Bellocci, F | 1 |
| Crea, F | 1 |
| Mah, D | 1 |
| Wang, A | 1 |
| Wu, A | 1 |
| Alexander, ME | 1 |
| Walsh, EP | 1 |
| Kanoupakis, EM | 1 |
| Manios, EG | 1 |
| Mavrakis, HE | 1 |
| Kallergis, EM | 1 |
| Lyrarakis, GM | 1 |
| Koutalas, EP | 1 |
| Vardas, PE | 1 |
| Wright, DJ | 1 |
| Cooke, GA | 1 |
| Tan, LB | 1 |
| Cice, G | 2 |
| Tagliamonte, E | 2 |
| Ferrara, L | 2 |
| Di Benedetto, A | 1 |
| Iacono, A | 2 |
| Melichercik, J | 1 |
| Goepfrich, M | 1 |
| Breidenbach, T | 1 |
| Von Hodenberg, E | 1 |
2 reviews available for carvedilol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Role of drug therapy for sustained ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Digoxin; Heart Conducti | 2008 |
[Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients].
Topics: Aged; Antihypertensive Agents; Carbazoles; Carvedilol; Female; Humans; Hypertension; Kidney Failure, | 1998 |
3 trials available for carvedilol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.
Topics: Action Potentials; Adrenergic beta-Antagonists; Aged; Blood Pressure; Carbazoles; Cardiomyopathy, Di | 2008 |
[Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients].
Topics: Aged; Antihypertensive Agents; Carbazoles; Carvedilol; Female; Humans; Hypertension; Kidney Failure, | 1998 |
Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2000 |
10 other studies available for carvedilol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carvedilol; Defibrillators, Implantable; Heart Fai | 2023 |
Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Carvedilol; Death, Sudden, Cardiac; Defibrillators, Implantable; | 2018 |
Non-β-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium; Carbazoles; Carvedilol; Heart Rate; HEK293 | 2015 |
Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cal | 2016 |
Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
Topics: Acute Disease; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diuretics; Drug Administration S | 2010 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H | 2009 |
Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2013 |
Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy.
Topics: Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Child; Electrocardiography; Humans; In | 2012 |
Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Humans; | 1997 |
Rise of defibrillation energy requirement under carvedilol therapy.
Topics: Aged; Carbazoles; Carvedilol; Combined Modality Therapy; Defibrillators, Implantable; Electric Capac | 2001 |